Abstract
Photo cross-linking of proteins with short RNA oligomers is a classical method to study RNA–protein interactions that are implicated in many aspects of RNA metabolism and function. Most commonly, this involves the use of [γ-32P]-labeled RNA probes. Although very sensitive, these procedures are complicated by the safety issues associated with the use of radioisotopes. Here, we describe a modified UV cross-linking method using oligonucleotide probes end labelled with the infrared dye IRDye®800. After UV cross-linking, proteins are separated by SDS-PAGE and cross-linked products are visualized with the Odyssey® Infrared Imaging system. This end labelling approach provides a streamlined alternative to random labelling which reduces the efficiency of in-vitro transcription. End labelling is also independent of the length of the probe, thus facilitating quantitative comparisons. To validate the method, we have confirmed the binding of HuD to the 3′-UTR of the mRNA for the microtubule-associated protein tau, implicated in the pathogenesis of Alzheimer’s disease. UV cross-linking of HuD with a labeled 21-mer probe was successfully performed using a recombinant purified glutathione-S-transferase–HuD fusion protein as well as with lysates from CHO cells transfected with HuD cDNA. UV cross-linking combined with infrared imaging offers a convenient and robust strategy to analyse RNA–protein interactions and their emerging importance in disease.
Highlights
All aspects of RNA metabolism and function, including premRNA splicing, mRNA stability and subcellular localization are regulated by RNA-binding proteins (RBPs, referred to as trans-acting factors) binding to specific elements in the target RNA [1]
A popular method to study the interaction between an RBP and a specific RNA sequence involves UV cross-linking of the protein with a [c-32P]-labelled RNA probe [5]
HuD binds to a U-rich region in the 30-UTR of tau mRNA, within a 91 base stem loop structure responsible for the selective localization of tau mRNA to the axon
Summary
All aspects of RNA metabolism and function, including premRNA splicing, mRNA stability and subcellular localization are regulated by RNA-binding proteins (RBPs, referred to as trans-acting factors) binding to specific elements in the target RNA [1]. Abnormal binding of RBPs to RNA has been linked to many pathological conditions, especially neurodegenerative diseases (for reviews see [3, 4]). Understanding the physiological function and pathological role of RBPs requires a reliable assay to demonstrate binding of specific proteins to RNA substrates. A popular method to study the interaction between an RBP and a specific RNA sequence involves UV cross-linking of the protein with a [c-32P]-labelled RNA probe [5].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.